docetaxel anhydrous has been researched along with piplartine in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (piplartine) | Trials (piplartine) | Recent Studies (post-2010) (piplartine) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 298 | 2 | 261 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | piplartine (IC50) |
|---|---|---|---|
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 7 | |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boakye, CHA; Chowdhury, N; Doddapaneni, R; Godugu, C; Patel, K; Singh, M | 1 |
| Christensen, M; Doughty, H; Kenealey, J; Lawson, J; Oblad, R | 1 |
2 other study(ies) available for docetaxel anhydrous and piplartine
| Article | Year |
|---|---|
Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Dioxolanes; Docetaxel; Drug Synergism; Female; Half-Life; Humans; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Taxoids; Triple Negative Breast Neoplasms | 2015 |
Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxolanes; Docetaxel; Drug Synergism; Flavonoids; Humans; Male; Mitoxantrone; Models, Statistical; Piperidines; Prostatic Neoplasms; Resveratrol; Taxoids | 2018 |